EP 0561901 A1 19930929 - USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF DIABETIC RETINOPATHY.
Title (en)
USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF DIABETIC RETINOPATHY.
Title (de)
VERWENDUNG VON ANGIOTENSIN-II-REZEPTORANTAGONISTEN BEI DER BEHANDLUNG DIABETISCHER RETINOPATHIE.
Title (fr)
UTILISATION D'AGENTS ANTAGONISTES DU RECEPTEUR DE L'ANGIOTENSINE II DANS LE TRAITEMENT DE LA RETINOPATHIE DIABETIQUE.
Publication
Application
Priority
GB 9027211 A 19901214
Abstract (en)
[origin: WO9210183A1] The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of diabetic retinopathy.
Abstract (fr)
L'invention se rapporte à l'utilisation d'un agent, antagoniste du récepteur de l'angiotensine II, dans la fabrication d'un médicament servant au traitement de la rétinopathie diabétique.
IPC 1-7
IPC 8 full level
A61K 31/415 (2006.01); A61K 31/42 (2006.01); A61K 31/425 (2006.01); A61K 31/44 (2006.01); A61K 31/47 (2006.01); A61P 3/08 (2006.01); A61P 3/10 (2006.01); A61P 27/02 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 31/415 (2013.01); A61K 31/44 (2013.01); A61K 31/47 (2013.01); A61P 3/08 (2017.12); A61P 3/10 (2017.12); A61P 27/02 (2017.12); A61P 43/00 (2017.12)
Citation (search report)
See references of WO 9210183A1
Designated contracting state (EPC)
BE CH DE FR GB IT LI NL
DOCDB simple family (publication)
WO 9210183 A1 19920625; AU 9064991 A 19920708; EP 0561901 A1 19930929; GB 9027211 D0 19910206; JP H06503335 A 19940414
DOCDB simple family (application)
GB 9102221 W 19911212; AU 9064991 A 19911212; EP 92900718 A 19911212; GB 9027211 A 19901214; JP 50172892 A 19911212